(Q38367554)

2 September 2017

1 reference

title

The Pneumovirinae fusion (F) protein: A common target for vaccines and antivirals (English)

1 reference

2 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738581%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Vicente Mas

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738581%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

José A Melero

series ordinal

1

1 reference

2 September 2017

Vicente Mas

series ordinal

2

1 reference

2 September 2017

publication date

1 March 2015

1 reference

2 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738581%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

209

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738581%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

128-135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738581%20AND%20SRC:MED&resulttype=core&format=json

Strategic priorities for respiratory syncytial virus (RSV) vaccine development

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Inhibition of respiratory viruses by nasally administered siRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

RSV604, a novel inhibitor of respiratory syncytial virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Orally active fusion inhibitor of respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Post-translational Processing and Oligomerization of the Fusion Glycoprotein of Human Respiratory Syncytial Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Integrin alphavbeta1 promotes infection by human metapneumovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Oral GS-5806 activity in a respiratory syncytial virus challenge study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Small molecules VP-14637 and JNJ-2408068 inhibit respiratory syncytial virus fusion by similar mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Respiratory syncytial virus infection in elderly and high-risk adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Respiratory syncytial viral infection in children with compromised immune function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Immunity to and frequency of reinfection with respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

In vivo inhibition of respiratory syncytial virus by ribavirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Paramyxovirus fusion: a hypothesis for changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Identification of a conserved neutralization site in the first heptad repeat of the fusion protein of respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Intracellular processing, glycosylation, and cell surface expression of human metapneumovirus attachment glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Two novel fusion inhibitors of human respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Human metapneumovirus: review of an important respiratory pathogen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

7 January 2021

Human metapneumovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

A monomeric uncleaved respiratory syncytial virus F antigen retains prefusion-specific neutralizing epitopes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Identification of nucleolin as a cellular receptor for human respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Proteolytic activation of respiratory syncytial virus fusion protein. Cleavage at two furin consensus sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

inferred from DOI database lookup

7 January 2021

based on heuristic

The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

inferred from DOI database lookup

7 January 2021

based on heuristic

Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2015.02.024

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2015.02.024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25738581%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

1 reference